Cargando…
Association of Acute Interstitial Nephritis with Nivolumab in Renal Cell Carcinoma: A Case Report
Recently, a number of innovative anticancer agents such us the programmed death 1 (PD-1) immune checkpoint inhibitors have been developed. Nevertheless, this type of immunotherapy may be associated with immune-related adverse events whose pathophysiology is considered similar to those found in autoi...
Autores principales: | Noto-Kadou-Kaza, Befa, Desbuissons, Geoffroy, Isnard, Corinne Bagnis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8330651/ https://www.ncbi.nlm.nih.gov/pubmed/34376950 http://dx.doi.org/10.4103/ijn.IJN_62_20 |
Ejemplares similares
-
Refractory Acute Interstitial Nephritis in the Setting of Nivolumab Therapy
por: Faieta, Antonio, et al.
Publicado: (2021) -
Acute Interstitial Nephritis With Karyomegalic Epithelial Cells After Nivolumab Treatment—Two Case Reports
por: Ryuzaki, Masaki, et al.
Publicado: (2019) -
Acute interstitial nephritis after sequential ipilumumab - nivolumab therapy of metastatic melanoma
por: Bottlaender, Lea, et al.
Publicado: (2017) -
Karyomegalic Interstitial Nephritis: A Case Report and Review of the Literature
por: Isnard, Pierre, et al.
Publicado: (2016) -
Hémodialyse chronique et dépression au Centre Hospitalier Universitaire Sylvanus Olympio de Lomé (Togo)
por: Tsevi, Mawufemo Yawovi, et al.
Publicado: (2016)